688712 北芯生命
已收盘 03-06 15:00:01
资讯
新帖
简况
北芯生命:公司核心产品IVUS系统于2024年在欧洲获批上市
证券日报 · 03-02
北芯生命:公司核心产品IVUS系统于2024年在欧洲获批上市
每周股票复盘:北芯生命(688712)2025年净利增284.93%
证券之星 · 03-01
每周股票复盘:北芯生命(688712)2025年净利增284.93%
北芯生命发布2025年度业绩快报,盈利0.806亿元
证券之星 · 02-27
北芯生命发布2025年度业绩快报,盈利0.806亿元
北芯生命正式登陆科创板 心血管精准诊疗格局加速重构
21世纪经济报道 · 02-06
北芯生命正式登陆科创板 心血管精准诊疗格局加速重构
北芯生命(688712.SH)股票将于2月5日在上科创板上市
智通财经 · 02-03
北芯生命(688712.SH)股票将于2月5日在上科创板上市
北芯生命(688712.SH):网上发行最终中签率为0.0326%
中金财经 · 01-26
北芯生命(688712.SH):网上发行最终中签率为0.0326%
A股申购 | 北芯生命(688712.SH)开启申购 专注于心血管疾病诊疗领域
智通财经 · 01-26
A股申购 | 北芯生命(688712.SH)开启申购 专注于心血管疾病诊疗领域
【新股】一图读懂北芯生命
中金财经 · 01-23
【新股】一图读懂北芯生命
加载更多
公司概况
公司名称:
深圳北芯生命科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2026-02-05
主营业务:
深圳北芯生命科技股份有限公司主营业务是心血管疾病精准诊疗创新医疗器械研发、生产和销售。主要产品是IVUS系统、FFR系统、血管通路产品、冲击波球囊治疗系统、电生理解决方案。公司曾获得龙华区2023年度中小微创新100强企业、广东省省级制造业单项冠军企业、第十批优秀国产医疗设备产品(北芯血管内超声诊断仪(VH60))、深圳市2023年龙华区创新产品与服务目录(FFR、IVUS、微导管、延长导管)等荣誉及奖项。
发行价格:
17.52
{"stockData":{"symbol":"688712","market":"SH","secType":"STK","nameCN":"北芯生命","latestPrice":39.87,"timestamp":1772780401000,"preClose":37.57,"halted":0,"volume":5081446,"delay":0,"changeRate":0.0612,"floatShares":37114700,"shares":417000000,"eps":0.1578,"marketStatus":"已收盘","change":2.3,"latestTime":"03-06 15:00:01","open":37.17,"high":39.97,"low":37.17,"amount":199000000,"amplitude":0.0745,"askPrice":39.88,"askSize":128,"bidPrice":39.87,"bidSize":67,"shortable":0,"etf":0,"ttmEps":0.1578,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773019800000},"marketStatusCode":5,"adr":0,"adjPreClose":37.57,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772760600000,1772767800000],[1772773200000,1772780400000]],"highLimit":41.33,"lowLimit":33.81,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":417000000,"isCdr":false,"pbRate":20.88,"roa":"--","peRate":252.661597,"roe":"10.64%","epsLYR":-0.12,"committee":-0.232975,"marketValue":16626000000,"turnoverRate":0.1369,"status":0,"afterMarket":{"amount":7974,"volume":200,"close":39.87,"buyVolume":0,"sellVolume":19,"time":1772782437558,"indexStatus":"已收盘 03-06 15:30:00","preClose":37.57},"floatMarketCap":1480000000},"requestUrl":"/m/hq/s/688712","defaultTab":"news","newsList":[{"id":"2616584333","title":"北芯生命:公司核心产品IVUS系统于2024年在欧洲获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2616584333","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616584333?lang=zh_cn&edition=full","pubTime":"2026-03-02 21:38","pubTimestamp":1772458680,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月2日,北芯生命在互动平台回答投资者提问时表示,公司核心产品IVUS系统于2024年在欧洲获批上市,为首个在海外获批上市(欧盟MDR)的国产IVUS产品;核心产品FFR系统于2020年在欧洲获批上市,为首个在海外获批上市(欧盟MDR)的国产FFR产品,产品凭借有显著临床价值的差异化创新,在满足过往未被完全满足的重要临床需求方面,持续获得国内外专家的广泛认可,产品已进入全球超过60个国家和地区,在超过2000家医院实现临床应用。产品暂未进入美国市场。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-02/doc-inhprfsc4458451.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-02/doc-inhprfsc4458451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688712","BK0251"],"gpt_icon":0},{"id":"2616431398","title":"每周股票复盘:北芯生命(688712)2025年净利增284.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616431398","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616431398?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:05","pubTimestamp":1772301916,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,北芯生命报收于41.18元,较上周的39.48元上涨4.31%。本周,北芯生命2月27日盘中最高价报41.8元。本周关注点业绩披露要点:北芯生命2025年归母净利润8,062.19万元,同比增长284.93%。公司公告汇总:北芯生命2025年海外市场收入同比增长超130%。公司公告汇总深圳北芯生命科技股份有限公司发布2025年度业绩快报,营业总收入54,210.81万元,同比增长71.23%;营业利润8,906.80万元,实现扭亏为盈。归属于母公司所有者的净利润8,062.19万元,上年同期为亏损4,359.62万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688712"],"gpt_icon":0},{"id":"2614588073","title":"北芯生命发布2025年度业绩快报,盈利0.806亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614588073","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614588073?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:31","pubTimestamp":1772181089,"startTime":"0","endTime":"0","summary":"证券之星消息,北芯生命近日即将发布2025年年报,根据2月27日发布的业绩快报,归属净利润盈利0.806亿元,同比增长284.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700026564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688712","BK0251"],"gpt_icon":0},{"id":"2609533633","title":"北芯生命正式登陆科创板 心血管精准诊疗格局加速重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2609533633","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609533633?lang=zh_cn&edition=full","pubTime":"2026-02-06 07:00","pubTimestamp":1770332400,"startTime":"0","endTime":"0","summary":"科创板“第五套标准”重启后首家成功上市的创新医疗器械企业正式诞生。 2月5日,深圳北芯生命科技股份有限公司正式在上海证券交易所科创板上市,发行价格为17.52元/股,发行5700万股,公开发行股票的比例占本次发行后公司总股本的13.67%。 同花顺数据显示,北芯生命当天以50.31元/股高开,盘内涨幅一度超210%。但毋庸置疑,北芯生命的成功上市,将加快重塑心血管疾病精准诊疗创新医疗器械的研发格局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-02-06/doc-inhkvret2324506.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-06/doc-inhkvret2324506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688712","159982"],"gpt_icon":0},{"id":"2608873052","title":"北芯生命(688712.SH)股票将于2月5日在上科创板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2608873052","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608873052?lang=zh_cn&edition=full","pubTime":"2026-02-03 20:09","pubTimestamp":1770120576,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北芯生命(688712.SH)发布公告,公司股票将于2026年2月5日在上海证券交易所科创板上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"北芯生命(688712.SH)股票将于2月5日在上科创板上市","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688712","159982"],"gpt_icon":0},{"id":"2606183248","title":"北芯生命(688712.SH):网上发行最终中签率为0.0326%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606183248","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606183248?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:57","pubTimestamp":1769432226,"startTime":"0","endTime":"0","summary":"回拨机制启动后,网下最终发行数量为3,192.0000万股,占扣除最终战略配售数量后发行数量的70.00%;网上最终发行数量为1,368.0000万股,占扣除最终战略配售数量后发行数量的30.00%。回拨机制启动后,网上发行最终中签率为0.03264275%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260126/31973172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688712"],"gpt_icon":0},{"id":"2606269584","title":"A股申购 | 北芯生命(688712.SH)开启申购 专注于心血管疾病诊疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2606269584","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606269584?lang=zh_cn&edition=full","pubTime":"2026-01-26 06:29","pubTimestamp":1769380189,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,1月26日,北芯生命开启申购,发行价格为17.52元/股,申购上限为0.9万股,行业市盈率41.36倍,属于上交所,中金公司为其保荐机构。招股书显示,北芯生命是一家专注于心血管疾病精准诊疗创新医疗器械研发、生产和销售的技术企业,亦致力于开发为心血管疾病诊疗带来变革的精准解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688712","399300","159982"],"gpt_icon":0},{"id":"2605742546","title":"【新股】一图读懂北芯生命","url":"https://stock-news.laohu8.com/highlight/detail?id=2605742546","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605742546?lang=zh_cn&edition=full","pubTime":"2026-01-23 13:14","pubTimestamp":1769145248,"startTime":"0","endTime":"0","summary":"证券之星消息,北芯生命1月26日网上申购,申购代码为787712,中签号公布日期为1月28日。该股概况请见下图: 为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/23/20260123504386.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/23/20260123504386.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260123/31966886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688712"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772899534572,"stockEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":1.2757},{"period":"ytd","weight":1.2757}],"compareEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳北芯生命科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"33684人(较上一季度增加84110.00%)","perCapita":"1101股","listingDate":"2026-02-05","address":"广东省深圳市龙华区民治街道北站社区鸿荣源北站中心A塔2102","registeredCapital":"41700万元","survey":" 深圳北芯生命科技股份有限公司主营业务是心血管疾病精准诊疗创新医疗器械研发、生产和销售。主要产品是IVUS系统、FFR系统、血管通路产品、冲击波球囊治疗系统、电生理解决方案。公司曾获得龙华区2023年度中小微创新100强企业、广东省省级制造业单项冠军企业、第十批优秀国产医疗设备产品(北芯血管内超声诊断仪(VH60))、深圳市2023年龙华区创新产品与服务目录(FFR、IVUS、微导管、延长导管)等荣誉及奖项。","listedPrice":17.52},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北芯生命(688712)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北芯生命(688712)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北芯生命,688712,北芯生命股票,北芯生命股票老虎,北芯生命股票老虎国际,北芯生命行情,北芯生命股票行情,北芯生命股价,北芯生命股市,北芯生命股票价格,北芯生命股票交易,北芯生命股票购买,北芯生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北芯生命(688712)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北芯生命(688712)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}